0Suppliers
5Customers
1Debt Items
4Related Chains

Source-Backed Evidence Depth

Connect Biopharma Holdings Limited (CNTB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

7Total relationships
1Distinct source URLs
3High confidence
0.743Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Connect Biopharma Holdings Limited Suppliers

No suppliers on recordConnect Biopharma Holdings Limited has not yet been matched to upstream suppliers in our database, or is still being processed.

Connect Biopharma Holdings Limited Customers

TickerNameConfidenceEvidence
SIMCERE SIMCERE 92% The Company recognized the revenue associated with the transfer of the intellectual property and know-how and transfer of the current manufacturing process were recognized at a point in time upon suc…
PANACEA-INNOVATION-LIMITED PANACEA-INNOVATION-LIMITED 62% ated stand-alone selling price for the license using a discounted cash flows model, which is an income approach. In estimating the stand-alone selling price for each performance obligation, the Compa…
SIM Grupo Simec, S.A.B. de C.V. 62% Reciprocal relationship from SIM graph: Reciprocal relationship from CNTB graph: Reciprocal relationship from SIM graph: Reciprocal relationship from CNTB graph: Reciprocal relationship from SIM grap…
SIMCERE-PHARMACEUTICAL-CO-LTD SIMCERE-PHARMACEUTICAL-CO-LTD 62% idered to be ordinary share equivalents and are included in the calculation of diluted net loss per share only when their effect is dilutive. Because we incurred a net loss for the three months ended…
SIMCERE-PHARMACEUTICAL-GROUP-LTD SIMCERE-PHARMACEUTICAL-GROUP-LTD 62% idered to be ordinary share equivalents and are included in the calculation of diluted net loss per share only when their effect is dilutive. Because we incurred a net loss for the three months ended…

Connect Biopharma Holdings Limited Debt Obligations

InstrumentDescriptionConfidenceEvidence
CNTB-DEBT Debt stack $693,000 90% Market cache reports total debt of $693,000.

Connect Biopharma Holdings Limited Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Connect Biopharma Holdings Limited.

Connect Biopharma Holdings Limited Ownership

HolderNameConfidenceEvidence
CNTB-OWNER-EVERSOURCE-WEALTH-ADVISORS-LLC EverSource Wealth Advisors, LLC 90% 13F overlay lists EverSource Wealth Advisors, LLC as top holder; 1 tracked holders.

Connect Biopharma Holdings Limited Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SIM Grupo Simec, S.A.B. de C.V. 100.00 1 ['customer']
CMC Commercial Metals Company 50.00 2
AEP American Electric Power Company, Inc. 50.00 2
MT ArcelorMittal S.A. 50.00 2
🔐
CNTB
Unlock CNTB Supply Chain Data
Verified relationships include:
SIMCERESIMCERECustomer92%
PANACEA-INNOVATION-LIMITEDPANACEA-INNOVATION-LIMITEDCustomer62%
+3 more relationships locked
Subscribe — View plans →